SP2 Antibody

What are the two main types of SP2 antibodies used in research?

Based on current research literature, there are two distinct SP2 antibodies that researchers should be aware of:

• SP2 Transcription Factor Antibodies: These antibodies target Sp2 transcription factor (also known as KIAA0048), a 613 amino acid protein containing 3 C2H2-type zinc fingers that belongs to the sp1 C2H2-type zinc finger protein family. These antibodies are used to study SP2's role in gene regulation and cancer progression .

• Progesterone Receptor Clone SP2 Antibodies: These are rabbit monoclonal antibodies (clone SP2) that target progesterone receptor (PR) protein in tissues, particularly in breast cancer research. These antibodies are not targeting SP2 protein but are named after the SP2 clone designation .

What are the main applications for SP2 transcription factor antibodies?

SP2 transcription factor antibodies have been validated for several laboratory applications:

The antibodies show reactivity with human and rat samples, with positive detection in cell lines including Jurkat cells, HEK-293 cells, K-562 cells, and C6 cells .

What is the cellular localization and molecular properties of SP2 transcription factor?

SP2 transcription factor:

• Cellular Localization: Nuclear

• Function: Binds to box promoter elements and selectively activates mRNA synthesis from genes containing functional recognition sites

• Calculated Molecular Weight: 65 kDa

• Observed Molecular Weight: 72 kDa

• Gene ID (NCBI): 6668

• GenBank Accession Number: BC016680

• UNIPROT ID: Q02086

SP2 may regulate the expression of the T-cell antigen receptor (TCR) gene and has been implicated in cancer progression through various molecular pathways .

How does the SP2 transcription factor influence cancer progression?

Research on hepatocellular carcinoma (HCC) has revealed significant insights into SP2's role in cancer:

• Expression Patterns: SP2 is significantly upregulated in HCC tissues compared to adjacent non-neoplastic tissues (ANT)

• Clinical Correlation: Higher SP2 expression is strongly associated with advanced tumor stage and poor patient prognosis

• Functional Effects: Knockdown of SP2 in HCC cell lines results in:

  • Decreased cell proliferation

  • Increased cell apoptosis

  • Inhibited cell migration and invasion abilities

• Molecular Mechanism: SP2 silencing inhibits the expression of TRIB3 protein and downregulates endoplasmic reticulum stress (ERS) levels in HCC

These findings suggest that SP2 overexpression may be associated with HCC occurrence and evolution, potentially serving as a new prognostic and diagnostic indicator for this cancer type .

What advantages do rabbit monoclonal SP2 antibodies offer over mouse monoclonals?

The rabbit monoclonal SP2 antibody for progesterone receptor detection offers several significant advantages:

• Superior Affinity: The antibody affinity of SP2 is 12 times higher than that of the commonly used mouse monoclonal antibody clone 1A6

• Enhanced Immunostaining Quality:

  • Predominant nuclear immunostaining with very low cytoplasmic background signal

  • Functions without requiring heat-based antigen retrieval of fixed-embedded tissue sections

• Comparative Performance: A study on 107 histological specimens from breast cancer cases demonstrated that SP2 yields the same diagnostic results as the well-established mouse mAb to PgR (clone 1A6), but with improved sensitivity

• General Advantages of Rabbit mAbs:

  • Higher sensitivity for IHC applications

  • Distinctive antibody repertoires with higher diversity, affinity, and specificity

  • More successful in recognizing difficult epitopes due to the unique ontogeny of rabbit B cells

How do the unique properties of rabbit antibody development contribute to SP2 antibody performance?

The exceptional properties of rabbit-derived antibodies, including the SP2 clone, can be attributed to their distinctive B-cell development:

• Unique B-cell Ontogeny: Rabbit B cells undergo a specialized development process that produces antibody repertoires that are:

  • Rich in in vivo pruned binders

  • Highly diverse

  • Characterized by high affinity and specificity

• Structural Advantages: Rabbit antibodies often feature:

  • More diverse complementarity-determining regions (CDRs)

  • Particularly diverse light chains with dominant LCDR3 roles in antigen binding

  • Alternative intrachain disulfide bridges in certain allotypes (e.g., b9 κ-light-chain allotype)

• Development Technologies: Rabbit monoclonal antibodies can be generated through:

  • Hybridoma technology (rabbit-mouse hetero-hybridomas)

  • Phage display using chimeric rabbit/human Fab libraries

  • Alternative recombinant methods

These unique developmental characteristics explain why rabbit monoclonal antibodies like SP2 have shown higher sensitivity compared to mouse monoclonal counterparts in various applications, particularly in immunohistochemistry .

What are the recommended protocols for using SP2 antibody in immunohistochemistry?

For the Progesterone Receptor [SP2] antibody, the following protocol parameters are recommended:

Dilution Guidelines:

• Concentrated format: 1:100-1:200 dilution

• Prediluted format: Ready-to-use

• Recommended diluent: Renoir Red (for concentrated format)

Sample Preparation:

• Formalin-fixed, paraffin-embedded (FFPE) tissues

• Positive control: Progesterone receptor positive breast carcinoma

Detection Method:

• Antigen detection follows a multi-step immunohistochemical process

• Initial binding of primary antibody (SP2) to its specific epitope

• Addition of enzyme-labeled polymer to bind to the primary antibody

• Detection through a colorimetric reaction

Special Considerations:

• Unlike many other antibodies, SP2 clone can function without heat-based antigen retrieval, which is a significant advantage in certain laboratory workflows

What are the optimal conditions for using SP2 transcription factor antibody in Western blotting?

Based on the product information for SP2 transcription factor antibody:

Sample Preparation:

• Effective with cell lysates from Jurkat cells, HEK-293 cells, K-562 cells, and C6 cells

Dilution Range:

• Recommended dilution: 1:200-1:1000 for Western blot applications

Expected Results:

• Calculated molecular weight: 65 kDa

• Observed molecular weight: 72 kDa

Storage and Handling:

• Store at -20°C

• Stable for one year after shipment

• Aliquoting unnecessary for -20°C storage

• Stored in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3

How should researchers validate SP2 antibody specificity?

To ensure reliable results, validation of SP2 antibody specificity should follow these methodological steps:

• Positive and Negative Controls:

  • For SP2 transcription factor: Use cell lines with known expression (Jurkat, HEK-293, K-562, C6 cells)

  • For Progesterone Receptor [SP2]: Use progesterone receptor positive breast carcinoma as positive control

• Multiple Detection Methods:

  • Cross-validate findings using different techniques (IHC, WB, IF) to ensure consistent detection

• Knockdown/Knockout Validation:

  • Test antibody specificity in samples where the target has been depleted through siRNA or CRISPR methods

  • As demonstrated in HCC research, SP2 knockdown should result in loss of signal if the antibody is specific

• Tissue Microarray Testing:

  • For clinical applications, testing on multi-tissue microarrays (TMAs) can help validate specificity across diverse tissue types

• Comparative Analysis:

  • Compare results with other validated antibodies targeting the same protein (especially important for Progesterone Receptor [SP2] validation)

How should researchers address non-specific binding when using SP2 antibodies?

When encountering non-specific binding with SP2 antibodies, consider these methodological solutions:

• Optimization of Antibody Concentration:

  • Titrate the antibody to determine optimal concentration

  • For SP2 transcription factor antibody: Test dilutions within the 1:200-1:1000 range

  • Note that optimal concentration may be sample-dependent

• Blocking Optimization:

  • Increase blocking time or concentration

  • Try alternative blocking agents (BSA, normal serum, commercial blockers)

  • For specimens containing endogenous biotin, use avidin/biotin blocking systems

• Washing Protocol Adjustment:

  • Increase number or duration of washing steps

  • Ensure use of appropriate washing buffer

• Background Reduction for IHC:

  • An advantage of Progesterone Receptor [SP2] antibody is its predominant nuclear staining with minimal cytoplasmic background signal

  • If background persists, consider:

    • Shorter incubation times

    • More stringent washing

    • Optimized antigen retrieval methods

• Cross-Reactivity Assessment:

  • Review the known reactivity profile (human, rat for SP2 transcription factor antibody)

  • Test negative control samples lacking the target protein

What factors influence the selection between different SP2 antibody formats?

When selecting between different formats of SP2 antibodies, researchers should consider:

• Application Requirements:

  • For Western blotting: Concentrated formats with appropriate dilution ranges (1:200-1:1000)

  • For IHC: Both concentrated (1:100-1:200) and prediluted (ready-to-use) formats are available

• Format-Specific Advantages:

  • For phage display applications: The chimeric rabbit/human Fab format provides:

    • More robust monomeric nature allowing affinity-driven selections

    • Avoids the tendency to dimerize/multimerize seen with scFv formats

    • Can be converted to other formats (like scFv) after selection if needed

• Host Species Considerations:

  • Rabbit monoclonal antibodies often show higher sensitivity for IHC applications

  • Consider species cross-reactivity when working with non-human samples

• Research Stage:

  • For preliminary studies: Smaller size vials may be sufficient

  • For established protocols: Larger volumes of ready-to-use formats may be more convenient

• Molecular Properties:

  • Single-domain antibody formats (VL or VH alone) derived from rabbit antibodies may offer advantages for recognizing cryptic epitopes due to their smaller size

How can researchers optimize SP2 antibody use for challenging tissue samples?

When working with challenging tissue samples, the following methodological approaches can improve SP2 antibody performance:

• Antigen Retrieval Optimization:

  • A key advantage of the Progesterone Receptor [SP2] clone is its ability to function without heat-based antigen retrieval

  • For difficult samples when using SP2 transcription factor antibody:

    • Test different antigen retrieval methods (heat-induced vs. enzymatic)

    • Optimize pH and buffer composition

    • Adjust retrieval duration

• Fixation Considerations:

  • Both antibody types have been validated for formalin-fixed, paraffin-embedded tissues

  • For samples with extended fixation times, longer antigen retrieval may be necessary

• Signal Amplification Methods:

  • For low-abundance targets, consider:

    • Polymer-based detection systems

    • Tyramide signal amplification

    • Longer primary antibody incubation times

• Multi-antibody Approaches:

  • For progesterone receptor detection in challenging samples, parallel testing with different PR antibody clones may provide complementary information

  • SP2 clone has been shown to have 12× higher affinity than the mouse mAb clone 1A6, making it valuable for difficult samples

• Control Selection:

  • Include gradation controls (weak, moderate, strong positive) alongside negative controls

  • This helps establish the detection threshold and validate staining patterns

What emerging applications might benefit from SP2 antibody technology?

Several emerging research areas could benefit from further development of SP2 antibody technology:

• Therapeutic Applications:

  • Rabbit mAbs, including derivatives of technologies used for SP2 antibody development, are increasingly being considered for therapeutic applications

  • The first rabbit mAb-derived therapeutics are already in clinical trials, suggesting potential for expanded use

• Cancer Biomarker Development:

  • SP2 transcription factor's role in hepatocellular carcinoma suggests potential as a prognostic and diagnostic biomarker

  • Further research could explore its utility in other cancer types

• Multiplexed Immunohistochemistry/Immunofluorescence:

  • High-sensitivity rabbit monoclonal antibodies like SP2 are ideal for multiplexed detection systems

  • Integration with spatial transcriptomics could provide deeper insights into tissue heterogeneity

• Single-Cell Analysis:

  • Adaptation of SP2 antibodies for single-cell protein detection technologies

  • Potential integration with single-cell RNA sequencing for multi-omic analysis

• Endoplasmic Reticulum Stress Pathways:

  • Given SP2's involvement in regulating endoplasmic reticulum stress in HCC, further exploration of this pathway could reveal new therapeutic targets

How might technological advances improve SP2 antibody development and applications?

Future technological developments that could enhance SP2 antibody utility include:

• Humanization Strategies:

  • Further refinement of rabbit antibody humanization for therapeutic applications

  • Building on established strategies that have already demonstrated success for rabbit mAbs

• Recombinant Production Optimization:

  • Enhanced expression systems for consistent batch-to-batch production

  • Development of stable cell lines with improved yields for recombinant rabbit antibodies

• Advanced Phage Display Technologies:

  • Continued improvement of chimeric rabbit/human Fab libraries

  • Novel selection strategies to identify antibodies with superior binding characteristics

• AI-Assisted Antibody Design:

  • Machine learning approaches to predict optimal rabbit antibody sequences

  • Computational optimization of antibody-antigen interactions

• Novel Antibody Formats:

  • Development of bispecific antibodies incorporating SP2 binding domains

  • Exploration of alternative scaffolds based on rabbit antibody frameworks